In preparing this article, we have relied heavily upon international sources whose assessment mechanisms are frequently unclear; consequently we have been careful in data interpretation. Information gaps exist in various areas that were of particular interest to us [8, 91, for example Cuba, which represents a singular Latin American experience in the nephrology context, and about which we do not have international data comparable to that used from other countries.
In broad strokes this article provides a picture of the state of nephrology in Latin America, points to some of our concerns, and indicates some of the initiatives that the Latin American Society of Nephrology and Hypertension (in Spanish, SLANH) has embarked upon on behalf of nephrology [10] [11] [12] . We have also sought to identify factors that may influence the development of nephrology in Latin America.
PRESENT STATE OF NEPHROLOGY IN LATIN AMERICA
Factors influencing nephrological development Nephrolo Societies. The Argentinean and Brazilian Nephrological Associations were established in 1960, coinciding with the founding of the International Society of Nephrology. Thus, the largest and most populated countries of the South American continent responded relatively quickly to the development of nephrology elsewhere in the world. The Latin American Society of Nephrology was founded in COrdoba, Argentina in 1970 (it was renamed Latin American Society of Nephrology and Hypertension in its 9th Congress in San Juan, Puerto Rico in 1994) and unites Latin American countries in one common society. In addition, SLANH claims as members Latin Americans residing in the United States who over the years have become major human and scientific resources, and have provided particular strength to the Society. SLANH has as its primary goal the unification into one society of all individuals of Latin American origin who practice nephrology in or outside Latin America (as defined above) in order to contribute to the dissemination of knowledge in the clinical and investigative aspects of the specialty in Latin America. In addition, SLANH promotes excellence in nephrological training and establishes courses of continuing medical education for nephrologists and health related nephrological specialists such as nurses, technicians and social workers. It also seeks to establish relationships with other nephrology societies with which it shares similar scientific and clinical pursuits, and which have a specified interest in the NA is not available. Table 2 . Listing and evaluation of nephrological resources that of the United States, Latin America has only 46% the number of nephrologists per million people (PMP) [15, 16] . This could be the result of a difference of 53% in the number of physicians PMP between the U.S. and Latin America. A low number of physicians can lead to erroneous interpretation of the meaning of the percent of physicians who are nephrologists in each country.
Bolivia, for example, has twice as many nephrologists PMP as the U.S., but it also has the second lowest number of physicians PMP in the region. Except for Argentina, Brazil, Uruguay and Venezuela, all countries have lower percentages of nephrologists out of the total population of physicians than the U.S. In contrast, eleven countries with at least 35% of the physicians PMP in the U.S. have greater numbers of nephrologists per physician than Canada;
three of those countries also surpass the numbers for Spain. The fact remains that Latin America has only 8.3 nephrologists PMP compared to 17.9 in the U.S. Table I also indicates that compared to Puerto Rico, the Latin American country that most closely parallels the U.S., there is a need for technicians and nurses (analyzed together because they perform similar duties in most of these countries) in most countries. Argentina and Uruguay are the only countries with numbers approaching those of Puerto Rico.
Renal replacement resources
The first hemodialysis therapy was carried out in Argentina in 1955 (10 years after the first one in the world), and the first kidney transplant was performed there in 1957 (3 years after the first in the world). Nevertheless, despite a significant growth in the delivery of nephrological services throughout Latin America, in general, dialysis and transplantation have lagged behind the rate of dialysis in most developed countries around the world. As shown in Table 2 , Bolivia (one of the poorest countries) with a population of over 8 million inhabitants has only 79 patients on hemodialysis; Argentina (one of the richest countries) has a population that represents 13% of the population of U.S., yet it only has 6% the U.S. number of dialysis patients. Brazil with over 161 million inhabitants or -60% the population of USA only has 9% of patients on dialysis as compared to the U.S.
There are -750 hemodialysis patients per million (PMP) in the United States. By contrast, Latin America has currently 34,977 (Table 2 ) recorded hemodialysis patients for 462 million people, a rate of 76 patients PMP, about one tenth that of the U.S. The highest number of dialysis patients PMP in Latin America is Puerto Rico, where the Medicare laws for the management of end-stage renal disease (ESRD) apply [17] .
In the United States peritoneal dialysis (CAPD/CCPD) accounts for one third of all end-stage renal disease therapy [18] . It should be clear from Table 2 that peritoncal dialysis represents slightly over 50% of all patients receiving a form of dialysis treatment. The reader should be aware that a large number of these patients actually receive intermittent acute dialysis rather than CAPD or CCPD.
Compared to the 71,000 transplants performed in the U.S. The high cost of dialysis, let alone transplantation, frequently clashes with the economic realities of each country. General health is frequently poor and this situation requires that these countries spend their limited resources on more urgent and immediate needs rather than on high technological procedures. Faced with high rates of poverty and illiteracy, both of which increase the mortality of children and infants and perinatal death of women, it is unlikely that any socially conscious government would assign a large portion of scarce resources to treat a few patients. In fact, we have calculated that hemodialysis costs to treat 600 patients per million would exceed the economic capability (GNP) of at least one country.
General health conditions of Latin America
There is a preponderance of communicable diseases in most of Politics and general health policy in the region Latin America as a region has suffered from chronic political instability, frequent institutional breakdowns, and inflationary problems, all circumstances that preclude reliable health policies and an adequate allocation of resources. These conditions were particularly prevalent in the sixties, which witnessed the birth of nephrology.
The nineties are a turning point: the trends that began in the eighties are becoming the general policies of the area. With few exceptions, there has been consolidation of democratic forms of government and a straightforward economic opening to world markets. The model of a market society has been adoptedadmittedly, to different extents-by all the countries, in harmony with world economic globalization. The main features of this decade are: (1) return to democratic forms of governing; (2) opening to national and international market economies; (3) establishment of regional economic agreements; (4) a movement toward financial recuperation; (5) state reorganization; and (6) privatization of public utilities and national corporations. As a result of these important changes, a number of improvements have been made that may ultimately contribute to better general health in the region. These include reduction of inflation, which is at least partly a product of the re-negotiation of the external debt and reduction of the public deficit as well as greater external investment. Most importantly, there has been significant state reorganization under more democratic structures.
It is heartening to note that these changes already have had some effect on nephrological development. In the past decade it has been possible to make inroads in the arduous business of having the governments of the region heed advice from interested parties in relation to renal diseases.
Dialysis policy
Countries such as Argentina, Brazil, Chile, Mexico and Uruguay have some form of policy for health insurance coverage for the patient in end-stage renal disease [8, 9] . These countries do not have laws comparable to the Medicare program for ESRD in the United States-of which Puerto Rico is the sole beneficiaryhowever, they are at the top of the economic developmental ladder in the area. Table 3 summarizes the information available from those countries where some form of law exists to cover renal therapy. Not surprisingly, the countries with the largest GNPs provide the best coverage for the renal patient and, generally speaking, include both dialysis and transplantation. Brazil, Chile and Uruguay provide insurance coverage for most of their patients. Venezuela, Argentina, Bolivia, Mexico and Peru provide coverage to from 10 to 60% of renal patients through their own form of social security. Spotty if not erratic coverage mostly for peritoneal dialysis and for limited hemodialysis is offered in El 
Nephrology as a detection and prevention subspecialty
We have already pointed Out that often the monetary resources needed for nephrological technology are above the gross national product of some countries. We feel that participation in detection and prevention in the chronic disease programs of health ministries, and the formation of alliances with public health workers, may be a way to convince governments that nephrologists in Latin America are interested in approaches other than technologysupported treatment. Two conditions that are particularly critical to identi' for potential prevention of renal disease are hypertension and diabetes mellitus. As health and economic conditions evolve in each country, an adequate coverage policy for those with ESRD could be developed that would allow greater nephrological development. It appears to us that multinational corporations, whose business includes dialysis procedures, should he called upon by governmental agencies and nephrological groups, including national societies of nephrology, to help develop economically feasible programs. It is reasonable to expect that adequate remuneration of nephrological services, particularly in the area of detection and prevention, could be an incentive to attract medical students to nephrology. Careful analysis of the local needs for nephrological expertise could also lead to improved planning of curricula in the discipline, and the inclusion of epidemiology and public health practices as they relate to detection and prevention.
PROSPECTS FOR DEVELOPMENT
The possibilities of developing opportunities for patients to have access to dialysis treatment upon reaching end-stage renal disease represent an ethical imperative [101 that must be the responsibility of every party involved in the care of the patient with kidney disease. Since we have considered an adequate dialysis policy as the main factor, Latin American national soci- eties of nephrology must take a leading role in the development of sound principles of treatment and resource allocation through which implementation can be pursued equitably and judiciously.
In addition, nephrology societies should be ready to present information to governmental agencies, to organize awareness campaigns addressed to the lay and scientific community and, particularly, to the community of renal patients. The Latin
American Society of Nephrology and Hypertension (SLANH) already plays a counseling role, supported by its scientific expertise, and has embarked on a concerted effort to organize regional meetings to exchange information about the existing models of legislation related to coverage and fees for the renal patient. SLANH is particularly worried with the future of nephrology training for Latin Americans. Changes in the number of fellowship offerings by programs in the U.S. in the years to come will limit access of all international graduates to U.S. training programs. Training programs in Latin America must he developed and those already in existence strengthened. These training programs should be based on the tenets that fundamental knowledge of internal medicine or pediatrics is necessary before specialization. Knowledge of public health and epidemiology as well as the basic sciences should be part of the curriculum if the graduates of these programs are to remain competitive within the field.
The international nephrological community must play an essential role in counseling governments on the most suitable technology for the particular situations of each country. The recently formed TSN Council on Global Development of Nephrology as well as committees of SLANH have begun a series of visits to countries in which education of political leaders may change the image of nephrology as more than a "dialysis and transplantation" specialty. The academic training of nephrology specialists in Latin America seems to be encouraged by these visits. In fact, the organization of regional scientific meetings with the presence of internationally known specialists has made a major impact in the area. In the past decade there has been a rapid growth of scientific meetings sponsored by ISN and SLANH; moreover, the develop- We suggest that scientific societies must review their almost exclusively academic missions and, without surrendering their primary scientific purposes, objectively analyze the teaching, learning, and practice of nephrology, particularly as these relate to detection and prevention of renal disease. They must properly examine, within the context of individual countries, the need and feasibility of developing dialysis and transplantation as treatments of end-stage renal disease in the regions of the world where presently these modalities are not optimal.
